Pharmaceutical compositions containing hollow fine tubular drug delivery systems
Abstract
@ Pharmaceutical compositions are provided which contain hollow fine tube drug delivery systems. The compositions comprise a pharmaceutically suitable carrier, preferably in the form of a capsule, tablet, suspension, or suppository, and at least one drug delivery system which consists essentially of (1) a polymeric tube having a membrane outer sheath and a hollow core, and (2) at least one drug compound contained within the core, said system contained in the composition in an amount sufficient to deliver a therapeutic amount of the drug contained therein at a predetermined rate over a predetermined period of time. By varying the polymer, the permeability of the outer sheath, the drug, the drug concentration in the hollow core of the tube, the tube diameter, the tube length, the tube core diameter, and the sealing of the tube ends, a wide variety of drug therapeutic amounts, rates and dosing times can be achieved.
Term
Term ended
Projected expiry passed 30 April 2006, 20.4 years ago.
- Priority
- Filed
- Published
- Projected expiry
- Today
Every citation, both ways
| Document | Relation | Office | Category | Cited during |
|---|---|---|---|---|
| EP0061192A1 | Cites | European Patent Office (EPO) | X | Search report |
| US3967618A | Cites | United States of America | A | Search report |
| US4017030A | Cites | United States of America | X | Search report |
| US4024871A | Cites | United States of America | A | Search report |
| US4237885A | Cites | United States of America | X | Search report |
27 members in 11 offices
Priority claims5
| Document | Office | Kind | Date |
|---|---|---|---|
| 730064 | United States of America | – | |
| 73006485 | United States of America | A | |
| 73006485 | United States of America | A | |
| 730064 | – | – | – |
| US19850730064 | – | – | – |
Members27
| Document | Office | Kind | |
|---|---|---|---|
| GR861145B | Greece | B | |
| IL78665A0 | Israel | A0 | |
| IL78665D0 | Israel | D0 | |
| EP0200224A2 | European Patent Office (EPO) | A2 | |
| AU5701186A | Australia | A | |
| JPS61268615A | Japan | A | |
| US4673565A | United States of America | A | |
| EP0200224A3This record | European Patent Office (EPO) | A3 | |
| US4720384A | United States of America | A | |
| ZA863314B | South Africa | B | |
| IL83595A0 | Israel | A0 | |
| AU7731387A | Australia | A | |
| EP0257560A1 | European Patent Office (EPO) | A1 | |
| JPS6351324A | Japan | A | |
| NZ216035A | New Zealand | A | |
| ZA876214B | South Africa | B | |
| AU584549B2 | Australia | B2 | |
| NZ221498A | New Zealand | A | |
| AU592664B2 | Australia | B2 | |
| CA1271306A | Canada | A | |
| IL78665A | Israel | A | |
| CA1284105C | Canada | C | |
| EP0200224B1 | European Patent Office (EPO) | B1 | |
| AT73650T | Austria | T | |
| ATE73650T1 | Austria | T1 | |
| DE3684354D1 | Germany | D1 | |
| IL83595A | Israel | A |
45 legal events, as 3 offices reported them to INPADOC
Over the term
Point at a mark for the eventEvents
| Event | Code | Office | |
|---|---|---|---|
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Notification of lapseLapsedST | ST | FR | |
| Nl: lapsed or anulled due to non-payment of the annual feeLapsedNLV4 | NLV4 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Gb: european patent ceased through non-payment of renewal feeCeasedGBPC | GBPC | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Be: lapsedLapsedBERE | BERE | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Se: european patent has lapsedLapsedEUG | EUG | EP | |
| Patent ceasedCeasedPL | PL | CH | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Se: european patent in force in swedenEAL | EAL | EP | |
| Lu: last paid annual feeEPTA | EPTA | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| No opposition filedOpposition26N | 26N | EP | |
| No opposition filed within time limitOppositionORIGINAL CODE: 0009261PLBE | PLBE | EP | |
| Information on the status of an ep patent application or granted ep patentGrantedSTATUS: NO OPPOSITION FILED WITHIN TIME LIMITSTAA | STAA | EP | |
| It: translation for a ep patent filedITF | ITF | EP | |
| It: translation for a ep patent filedITF | ITF | EP | |
| Corresponds to:REF | REF | EP | |
| Fr: translation filedET | ET | EP | |
| Designated contracting statesAK | AK | EP | |
| Corresponds to:REF | REF | EP | |
| (expected) grantORIGINAL CODE: 0009210GRAA | GRAA | EP | |
| Party data changed (applicant data changed or rights of an application transferred)RAP1 | RAP1 | EP | |
| First examination report despatched17Q | 17Q | EP | |
| Request for examination filed17P | 17P | EP | |
| Designated contracting statesAK | AK | EP | |
| Search report despatchedORIGINAL CODE: 0009013PUAL | PUAL | EP | |
| Designated contracting statesAK | AK | EP | |
| Public reference made under article 153(3) epc to a published international application that has entered the european phaseORIGINAL CODE: 0009012PUAI | PUAI | EP |
Numbers
- Publication
- 0200224
- Publication, DOCDB
- 0200224
- Publication, EPODOC
- EP0200224
- Application
- 86105970
- Application, DOCDB
- 86105970
- Application, EPODOC
- EP19860105970
Titles3
- English
- Pharmaceutical compositions containing hollow fine tubular drug delivery systems
- French
- Compositions pharmaceutiques contenant des systèmes à base de tubes fins et creux pour la libération des médicaments
- German
- Arzneimittel, die hohle, feine, röhrchenförmige Wirkstoffabgabesysteme enthalten
Classification
- CPC, 3
- A61K9/0092
- A61K9/70
- Y10S514/965
- IPC, 5
- A61K9 00
- A61J3 07
- A61K9 22
- A61K9 50
- A61K9 70
Designated states11
- Contracting states, 11
- Austria
- Belgium
- Switzerland
- Germany
- France
- United Kingdom
- Italy
- Liechtenstein
- Luxembourg
- Netherlands (Kingdom of the)
- Sweden